Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Operating Margin: 2010-2024

Historic Operating Margin for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -101.32%.

  • China Pharma Holdings' Operating Margin rose 1558.00% to -83.06% in Q3 2025 from the same period last year, while for Sep 2025 it was -79.83%, marking a year-over-year increase of 272.00%. This contributed to the annual value of -101.32% for FY2024, which is 6208.00% down from last year.
  • According to the latest figures from FY2024, China Pharma Holdings' Operating Margin is -101.32%, which was down 158.16% from -39.25% recorded in FY2023.
  • China Pharma Holdings' 5-year Operating Margin high stood at -23.73% for FY2020, and its period low was -101.32% during FY2024.
  • Moreover, its 3-year median value for Operating Margin was -43.79% (2022), whereas its average is -61.45%.
  • In the last 5 years, China Pharma Holdings' Operating Margin surged by 16,309bps in 2020 and then plummeted by 6,208bps in 2024.
  • Over the past 5 years, China Pharma Holdings' Operating Margin (Yearly) stood at -23.73% in 2020, then slumped by 594bps to -29.67% in 2021, then crashed by 1,412bps to -43.79% in 2022, then skyrocketed by 454bps to -39.25% in 2023, then plummeted by 6,208bps to -101.32% in 2024.